We are live on ! Find out more
RhumbLine Advisers

RhumbLine Advisers Portfolio holdings

AUM $117B
1-Year Est. Return 29.66%
This Fund
S&P 500
This Quarter Est. Return
+4.92%
1 Year Est. Return
+29.66%
3 Year Est. Return
+101.47%
5 Year Est. Return
+137.35%
10 Year Est. Return
+530.91%
AUM
$36.3B
AUM Growth
+$2.54B
Cap. Flow
+$1.28B
Cap. Flow %
3.53%
Top 10 Hldgs %
14.85%
Holding
3,030
New
42
Increased
2,539
Reduced
264
Closed
157

Top Buys

Rank Stock Value
1
CHTR icon
Charter Communications
CHTR
+$34.8M
2
AAPL icon
Apple
AAPL
+$33.7M
3
XOM icon
ExxonMobil
XOM
+$30M
4
MSFT icon
Microsoft
MSFT
+$25.3M
5
FTV icon
Fortive
FTV
+$24.2M

Sector Composition

Rank Sector Weight
1 Technology 14.71%
2 Financials 14.59%
3 Healthcare 13.89%
4 Industrials 10.54%
5 Consumer Discretionary 9.49%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
CULP icon
2376
Culp Inc
CULP
$44.2M
$369K ﹤0.01%
12,385
+250
+2% +$7.38K
VPG icon
2377
Vishay Precision Group
VPG
$1.22B
$366K ﹤0.01%
22,851
+50
+0.2% +$729
KMG
2378
DELISTED
KMG Chemicals Inc
KMG
$364K ﹤0.01%
12,844
+100
+0.8% +$2.76K
GEF.B icon
2379
Greif Class B
GEF.B
$4.11B
$363K ﹤0.01%
+5,992
New +$327K
SQBG
2380
DELISTED
Sequential Brands Group, Inc.
SQBG
$363K ﹤0.01%
1,135
+10
+0.9% +$3.05K
XENT
2381
DELISTED
Intersect ENT, Inc
XENT
$361K ﹤0.01%
22,771
+430
+2% +$6.48K
BRG
2382
DELISTED
Bluerock Residential Growth REIT, Inc.
BRG
$360K ﹤0.01%
27,730
+900
+3% +$12K
BCRX icon
2383
BioCryst Pharmaceuticals
BCRX
$2.24B
$359K ﹤0.01%
81,310
-19,144
-19% -$76.5K
GERN icon
2384
Geron
GERN
$821M
$359K ﹤0.01%
158,937
+2,060
+1% +$5.34K
MMI icon
2385
Marcus & Millichap
MMI
$1.16B
$359K ﹤0.01%
13,731
+130
+1% +$3.44K
VIRT icon
2386
Virtu Financial
VIRT
$5.12B
$359K ﹤0.01%
23,970
+400
+2% +$6.74K
ARAV
2387
DELISTED
Aravive, Inc. Common Stock
ARAV
$359K ﹤0.01%
4,880
+250
+5% +$18.1K
DFRG
2388
DELISTED
Del Frisco's Restaurant Group, Inc. Common Stock
DFRG
$359K ﹤0.01%
26,681
+120
+0.5% +$1.78K
SGMO
2389
DELISTED
SANGAMO THERAPEUTICS INC
SGMO
$357K ﹤0.01%
77,203
-570
-0.7% -$2.9K
LUMO
2390
DELISTED
Lumos Pharma, Inc. Common Stock
LUMO
$357K ﹤0.01%
2,638
-739
-22% -$73.4K
LIOX
2391
DELISTED
Lionbridge Technologies
LIOX
$357K ﹤0.01%
71,313
-985
-1% -$4.61K
CNXN icon
2392
PC Connection
CNXN
$2.16B
$356K ﹤0.01%
13,490
+150
+1% +$3.83K
GORO icon
2393
Goldgroup Mining Inc.
GORO
$164M
$356K ﹤0.01%
47,922
+6,000
+14% +$35.5K
ZGNX
2394
DELISTED
Zogenix, Inc.
ZGNX
$356K ﹤0.01%
31,135
+1,100
+4% +$10.1K
MLAB icon
2395
Mesa Laboratories
MLAB
$584M
$354K ﹤0.01%
3,094
-20
-0.6% -$2.28K
AT
2396
DELISTED
Atlantic Power Corporation
AT
$353K ﹤0.01%
143,036
+1,400
+1% +$3.52K
TNGO
2397
DELISTED
Tangoe, Inc.
TNGO
$353K ﹤0.01%
42,729
-8,920
-17% -$76.6K
MCF
2398
DELISTED
Contango Oil & Gas Co.
MCF
$352K ﹤0.01%
34,472
+5,095
+17% +$52.4K
UMH
2399
UMH Properties
UMH
$1.3B
$351K ﹤0.01%
29,407
+1,050
+4% +$12.7K
EXAC
2400
DELISTED
Exactech Inc
EXAC
$351K ﹤0.01%
12,986
+100
+0.8% +$2.75K

Similar funds

RhumbLine Advisers's Q3 2016 Portfolio in Review

As of Q3 2016, RhumbLine Advisers held 3,030 positions worth $36.3B, up 7.5% from $33.7B the previous quarter. Its ten largest holdings account for 15% of the portfolio.

RhumbLine Advisers deployed $1.28B of net new capital in Q3 2016, opening 42 new positions and adding to 2,539 existing holdings. Its largest new stake was Fortive: 753,372 shares worth $24.2M.

By sector, the portfolio is most concentrated in Technology at 15% of assets, up from 14% a quarter earlier, followed by Financials and Healthcare.

On the sell side, the largest reduction was Danaher, an estimated $24.4M trimmed.

  • RhumbLine Advisers's largest Q3 2016 buy was Fortive: 753,372 shares worth $24.2M.
  • RhumbLine Advisers added most to Charter Communications in Q3 2016, an estimated $34.8M increase.
  • RhumbLine Advisers's biggest Q3 2016 reduction was Danaher, cutting an estimated $24.4M.
  • RhumbLine Advisers fully exited EMC CORPORATION in Q3 2016, selling an estimated $81.1M.
  • RhumbLine Advisers's ten largest holdings make up 15% of its $36.3B portfolio in Q3 2016.
  • RhumbLine Advisers opened 42 new positions and closed 157 in Q3 2016.
  • RhumbLine Advisers's portfolio value rose 7.5% quarter-over-quarter to $36.3B.

Based on RhumbLine Advisers's 13F filing for Q3 2016, filed 8 Nov 2016.